CRIS Short Information, Curis Inc.
home / stock / cris / cris short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 19,487,089 |
| Total Actual Volume | 90,381,518 |
| Short Trends | |
|---|---|
| Cover Days | 4 |
| Short Days | 12 |
| No Change Days | 4 |
| Averages | |
|---|---|
| Average Short Volume | 974,354 |
| Average Short Percentage | 50.30% |
Is there a CRIS Short Squeeze or Breakout about to happen?
See the CRIS Short Analysis for free Sign up or Login
Powered by Squeeze Report
CRIS Twenty Trading Day's Volume to Short Volume Chart
CRIS Twenty Trading Day Price Chart
CRIS Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-06-23 | 0.985 | 1.07 | 1.07 | 0.985 | 1,977,138 | 272,010 | 29.8921 |
| 2022-06-22 | 0.96 | 0.9856 | 1.06 | 0.9401 | 2,250,306 | 232,026 | 25.5085 |
| 2022-06-21 | 1.03 | 0.9773 | 1.0699 | 0.9512 | 4,354,011 | 1,005,506 | 49.0563 |
| 2022-06-16 | 0.9251 | 0.9264 | 0.9571 | 0.871 | 3,581,937 | 984,578 | 52.3606 |
| 2022-06-15 | 1.03 | 0.9357 | 1.03 | 0.9201 | 5,647,552 | 1,341,846 | 51.7616 |
| 2022-06-14 | 1.07 | 1.04 | 1.08 | 1.02 | 2,885,915 | 451,556 | 34.8607 |
| 2022-06-13 | 0.94 | 1.07 | 1.07 | 0.91 | 5,995,949 | 1,637,870 | 54.6345 |
| 2022-06-09 | 1.02 | 1.06 | 1.08 | 0.944 | 5,278,930 | 1,033,931 | 45.0376 |
| 2022-06-08 | 1 | 1.05 | 1.1399 | 1 | 6,643,755 | 1,271,097 | 38.1832 |
| 2022-06-06 | 1.14 | 0.865 | 1.145 | 0.86 | 19,605,342 | 3,760,102 | 59.0029 |
| 2022-06-03 | 0.8101 | 0.94 | 1.07 | 0.8101 | 12,676,753 | 2,589,129 | 38.4425 |
| 2022-06-02 | 0.84 | 0.8099 | 0.84 | 0.7936 | 2,093,583 | 533,399 | 55.3044 |
| 2022-06-01 | 0.825 | 0.8 | 0.828 | 0.78 | 3,663,790 | 1,179,134 | 60.4177 |
| 2022-05-31 | 0.7339 | 0.7644 | 0.8161 | 0.7 | 5,727,761 | 1,253,262 | 59.0552 |
| 2022-05-27 | 0.7588 | 0.72 | 0.76 | 0.7028 | 1,761,527 | 505,980 | 73.3794 |
| 2022-05-26 | 0.731 | 0.7285 | 0.76 | 0.71 | 981,726 | 224,441 | 50.3644 |
| 2022-05-25 | 0.71 | 0.7281 | 0.7399 | 0.7081 | 1,102,728 | 276,200 | 64.1377 |
| 2022-05-24 | 0.766 | 0.7067 | 0.766 | 0.701 | 1,277,077 | 395,299 | 71.2173 |
| 2022-05-23 | 0.8042 | 0.7695 | 0.82 | 0.76 | 1,123,885 | 292,479 | 65.0062 |
| 2022-05-19 | 0.78 | 0.7942 | 0.8 | 0.75 | 1,751,853 | 247,244 | 28.4425 |
News, Short Squeeze, Breakout and More Instantly...
-
Curis Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies - Amends existing protocol of ongoing Phase 1 study in R/R NHL - - Initial data expected in the fourth quarter of 2021 - P...
-
Curis Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic Syndromes - Phase 2 study sponsored by investigators at Universität Leipzig in Germany - ...
-
Curis to Present at B. Riley Securities Virtual Oncology Investor Conference PR Newswire LEXINGTON, Mass. , Jan. 14, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment o...